NCT04754204

Brief Summary

To determine the associations among biometric data, arrhythmias, subject-reported symptoms and subject wellness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
585

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2020

Shorter than P25 for all trials

Geographic Reach
1 country

20 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 9, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 15, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2021

Completed
Last Updated

February 9, 2022

Status Verified

February 1, 2022

Enrollment Period

1 year

First QC Date

February 9, 2021

Last Update Submit

February 8, 2022

Conditions

Keywords

cardiacarrhythmia

Outcome Measures

Primary Outcomes (3)

  • Biometric Data Associations to Arrhythmias

    MCT Data Sets

    30 days

  • Biometric Data Associations to Subject-Reported Symptoms

    MCT Data Sets

    30 days

  • Biometric Data Associations to Subject Wellness

    MCT Data Sets

    30 days

Secondary Outcomes (3)

  • Clinician Use of Biometric Data Associations to Arrhythmias

    30 days

  • Clinician Use of Biometric Data Associations to Subject-Reported Symptoms

    30 days

  • Clinician Use of Biometric Data Associations to Wellness Status of Subject

    30 days

Study Arms (1)

Patients indicated for Mobile Cardiac Telemetry Monitoring

Patients indicated for Mobile Cardiac Telemetry Monitoring while meeting inclusion/exclusion criteria and enrolled in sequential manner.

Device: Arrhythmia Management System (AMS)

Interventions

AMS records rhythm, heart rate, subject-reported symptoms, and multiple parameters that include respiration rate, activity and body posture.

Patients indicated for Mobile Cardiac Telemetry Monitoring

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult subjects, 21 years or older who: 1. Require mobile cardiac telemetry monitoring for the detection of non-lethal cardiac arrhythmias 2. Are without any cardiac implantable electronic devices, including loop recorders 3. Are without wearable cardioverter defibrillator 4. Are without Holter monitors, wearable event recorders, and other mobile cardiac telemetry devices at the same time 5. Are not currently hospitalized 6. Do not have any skin condition that would prevent them from wearing the AMS device 7. Are not non-ambulatory 8. Are not reporting to be pregnant 9. Are not participating in another clinical study

You may qualify if:

  • Subjects who require monitoring for non-lethal cardiac arrhythmias
  • Subjects who have an indication for mobile cardiac telemetry (MCT) monitoring
  • Subjects 21 years of age or older

You may not qualify if:

  • Subjects with an implantable cardiac device such as left ventricular assistive device, pacemaker, implanted cardioverter defibrillator (ICD), cardiac resynchronization therapy device, subcutaneous ICD's, pressure monitors and loop monitors
  • Subjects with wearable cardioverter defibrillator, Holter monitors, wearable event recorders, and other mobile cardiac telemetry devices at the same time
  • Subjects currently hospitalized
  • Subjects with a skin condition preventing them from wearing the AMS device
  • Subjects who are non-ambulatory
  • Subjects who are self-reporting to be pregnant
  • Subjects participating in another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (20)

Comprehensive Cardiovascular Medical Group

Bakersfield, California, 93309, United States

Location

Cardiovascular Innovation and Research Center

Long Beach, California, 90813, United States

Location

Heartbeat Cardiovascular Medical Group

Los Angeles, California, 90027, United States

Location

Interventional Cardiology Group

West Hills, California, 91307, United States

Location

Flagler Hospital/Flagler Health

Jacksonville, Florida, 32086, United States

Location

Cardiovascular Institute of Central Florida

Ocala, Florida, 34476, United States

Location

First Coast Heart and Vascular Center

Saint Augustine, Florida, 32086, United States

Location

Cardiovascular Research of Northwest Indiana

Munster, Indiana, 46321, United States

Location

Cardiovascular Research of Northwest

Munster, Indiana, 46321, United States

Location

Jackson Heart Clinic

Jackson, Mississippi, 39216, United States

Location

Trinity Medical

Cheektowaga, New York, 14227, United States

Location

PMG Research of Wilmington

Wilmington, North Carolina, 28401, United States

Location

Erlanger Health System

Chattanooga, Tennessee, 37403, United States

Location

ClinicalTex Research LLC d/b/a PharmaTex Research

Amarillo, Texas, 79109, United States

Location

Texas Cardiology Associates of Houston

Kingwood, Texas, 77339, United States

Location

Heart Rhythm Specialists

McKinney, Texas, 75070, United States

Location

CardioVoyage

McKinney, Texas, 75071, United States

Location

Orion Medical Research

Pasadena, Texas, 77505, United States

Location

Daniel W. Gottlieb, MD, PS

Burien, Washington, 98166, United States

Location

St. Mary's Medical Center

Huntington, West Virginia, 25702, United States

Location

MeSH Terms

Conditions

Arrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ramu Perumal, PhD

    Zoll Services LLC

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2021

First Posted

February 15, 2021

Study Start

December 15, 2020

Primary Completion

December 15, 2021

Study Completion

December 15, 2021

Last Updated

February 9, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations